Edition:
India

Surmodics Inc (SRDX.OQ)

SRDX.OQ on NASDAQ Stock Exchange Global Select Market

30.10USD
1:54am IST
Change (% chg)

$-0.10 (-0.33%)
Prev Close
$30.20
Open
$30.05
Day's High
$30.25
Day's Low
$29.98
Volume
4,310
Avg. Vol
12,100
52-wk High
$32.80
52-wk Low
$22.50

Latest Key Developments (Source: Significant Developments)

Surmodics Q4 gaap earnings per share $0.03
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Surmodics Inc :Surmodics reports fourth quarter fiscal 2017 results and provides fiscal 2018 guidance.Q4 non-gaap earnings per share $0.18.Q4 gaap earnings per share $0.03.Q4 revenue $20.1 million versus i/b/e/s view $17.3 million.Q4 earnings per share view $-0.01 -- Thomson Reuters I/B/E/S.Sees fy 2018 non-gaap loss per share $0.16 to $0.41.Sees fy 2018 loss per share $0.50 to $0.75.Sees fy 2018 revenue $72 million to $75 million.Fy2018 earnings per share view $0.23 -- Thomson Reuters I/B/E/S.  Full Article

Surmodics reports Q3 non-gaap EPS $0.37
Thursday, 28 Jul 2016 

Surmodics Inc : Surmodics reports third quarter fiscal 2016 results . Raises FY 2016 non-gaap earnings per share view to $0.98 to $1.08 . Q3 gaap earnings per share $0.30 from continuing operations . Q3 revenue $20 million versus I/B/E/S view $16.3 million . Raises fy 2016 gaap earnings per share view to $0.52 to $0.59 . Sees fy 2016 revenue $68 million to $70 million . Q3 earnings per share view $0.12 -- Thomson Reuters I/B/E/S .FY2016 earnings per share view $0.78, revenue view $65.7 million -- Thomson Reuters I/B/E/S.  Full Article

SurModics Inc reaffirms FY 2016 guidance
Thursday, 28 Jan 2016 

SurModics Inc:Says it is reaffirming its previously stated guidance for FY 2016.Expects revenue to range from $62 million to $66 million, with diluted GAAP earnings in range of $0.30 to $0.35 per share and non-GAAP earnings of $0.66 to $0.75 per share.  Full Article

SurModics Inc acquires NorMedix
Monday, 11 Jan 2016 

SurModics Inc:Acquires Normedix, a design and development company focused on minimally invasive catheter technologies.Says Surmodics acquired normedix for $14 million, including an upfront payment of $7 million.Says other financial terms of the agreement were not disclosed.Says Surmodics is adjusting fiscal 2016 revenue guidance.Sees 2016 revenue $62 million to $66 million.Sees FY 2016 revenue guidance from a range of $60 million to $64 million to an adjusted range of $62 million to $66 million.  Full Article

BRIEF-Surmodics Q4 gaap earnings per share $0.03

* Surmodics reports fourth quarter fiscal 2017 results and provides fiscal 2018 guidance